Literature DB >> 11509616

Monomorphic molecules function as additional recognition structures on haptenated target cells for HLA-A1-restricted, hapten-specific CTL.

J Stöckl1, O Majdic, G Fischer, D Maurer, W Knapp.   

Abstract

Hapten-specific T cells have been shown to recognize haptenated peptides with high avidity and, in some instances, with promiscuous MHC restriction. In this study, the impact of Ag density on MHC restriction of a CTL response specific to the trinitrophenyl (TNP) hapten was investigated. In this study, we demonstrate a novel recognition mechanism used by TNP-specific CD8(+) CTL in the presence of high Ag doses. Although low levels of TNP epitopes on target cells allowed for HLA-A1-restricted CTL activity only, entirely MHC-independent target cell recognition became operative at high TNP loading. In both cases, recognition was mediated by the TCR. This MHC-independent recognition is target cell type restricted and critically involves in our model direct recognition of the ectonucleotidase family surface molecule CD39 by the CTL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509616     DOI: 10.4049/jimmunol.167.5.2724

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism.

Authors:  Maria E Moreno-Fernandez; Cesar Mauricio Rueda; Laura K Rusie; Claire A Chougnet
Journal:  Blood       Date:  2011-03-23       Impact factor: 22.113

Review 2.  Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions.

Authors:  Basil O Gerber; Werner J Pichler
Journal:  AAPS J       Date:  2006-03-17       Impact factor: 4.009

3.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance.

Authors:  Simon C Robson; Jean Sévigny; Herbert Zimmermann
Journal:  Purinergic Signal       Date:  2006-05-30       Impact factor: 3.765

4.  CD39 and control of cellular immune responses.

Authors:  Karen M Dwyer; Silvia Deaglio; Wenda Gao; David Friedman; Terry B Strom; Simon C Robson
Journal:  Purinergic Signal       Date:  2007-02-06       Impact factor: 3.765

Review 5.  On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy).

Authors:  Martín Candia; Bernhard Kratzer; Winfried F Pickl
Journal:  Int Arch Allergy Immunol       Date:  2016-09-20       Impact factor: 2.749

6.  Transferrin receptor 1 is a cellular receptor for human heme-albumin.

Authors:  Brell Jennifer; Verena Berg; Madhura Modak; Alexander Puck; Maria Seyerl-Jiresch; Sarojinidevi Künig; Gerhard J Zlabinger; Peter Steinberger; Janet Chou; Raif S Geha; Leopold Öhler; Akihiro Yachie; Hyeryun Choe; Markus Kraller; Hannes Stockinger; Johannes Stöckl
Journal:  Commun Biol       Date:  2020-10-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.